LLY Jan 2024 350.000 call
| Previous close | 229.00 |
| Open | 229.00 |
| Bid | 192.00 |
| Ask | 195.15 |
| Strike | 350.00 |
| Expiry date | 2024-01-19 |
| Day's range | 229.00 - 229.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 422 |
BloombergUpstart Weight-Loss Drugmaker Jumps 75% on Strong Test Results
(Bloomberg) -- Structure Therapeutics Inc. jumped to a record high Friday after new data on its oral weight-loss drug fueled expectations that the San Francisco-based company is closing the gap with larger competitors such as Pfizer Inc.Most Read from BloombergEurope’s Richest Royal Family Builds $300 Billion Finance EmpirePakistan Rupee Set to Become Top Performing Currency Globally Top Chinese Scientist Claims India Moon Landing Nowhere Near South PoleStock Optimism Fizzles as Quarterly Losses
Zacks3 Stocks to Focus on as Demand for Obesity Drugs Booms
With the obesity market gaining popularity, analysts are expecting sales to increase. Pharma companies are rushing to enter the market
ZacksNektar (NKTR), Cellular Biomedicine Join for Lung Cancer Studies
Nektar (NKTR) enters into a deal with Cellular Biomedicine Group to develop NKTR-255 in combination with C-TIL05 to treat advanced NSCLC.
